Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart Cart lightblue
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Location


Corporate Headquarters

Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States

Telephone Numbers



Customer Service: (800) 227-6666 / (650) 697-3600


Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C351950-100 100 µl (1 mg/ml) $299 
CD3D Antibody - Immunofluorescent analysis of CD3d staining in Jurkat cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 C in a humidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark. DAPI was used to stain the cell nuclei (blue).
CD3D Antibody - Western blot analysis of CD3d expression in CCRFCEM (A); Jurkat (B); HuT78 (C) whole cell lysates.
CD3D Antibody - Immunofluorescent analysis of CD3d staining in Jurkat cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 C in a humidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark. DAPI was used to stain the cell nuclei (blue).
CD3D Antibody - Western blot analysis of CD3d expression in CCRFCEM (A); Jurkat (B); HuT78 (C) whole cell lysates.
1 of 2
2 of 2

Polyclonal Rabbit anti‑Human CD3D Antibody (Internal, IF, WB) LS‑C351950

Polyclonal Rabbit anti‑Human CD3D Antibody (Internal, IF, WB) LS‑C351950

Antibody:
CD3D Rabbit anti-Human Polyclonal (Internal) Antibody
Application:
ICC, IF, WB
Reactivity:
Human, Monkey
Format:
Unconjugated, Unmodified
Price
Catalog Number
$299
LS-C351950-100
Toll Free North America
(800) 227-6666
For Research Use Only

Overview

Antibody:
CD3D Rabbit anti-Human Polyclonal (Internal) Antibody
Application:
ICC, IF, WB
Reactivity:
Human, Monkey
Format:
Unconjugated, Unmodified

Specifications

Description
CD3D antibody LS-C351950 is an unconjugated rabbit polyclonal antibody to CD3D (Internal) from human. It is reactive with human and monkey. Validated for ICC, IF and WB.
Target
Human CD3D
Synonyms
CD3D | CD3 delta | CD3d antigen | T-cell receptor T3 delta chain | T3D | CD3 antigen, delta subunit | CD3-DELTA | OKT3, delta chain
Host
Rabbit
Reactivity
Human, Monkey (tested or 100% immunogen sequence identity)
Clonality
Polyclonal
Conjugations
Unconjugated
Purification
Immunoaffinity purified
Modifications
Unmodified
Immunogen
KLH-conjugated synthetic peptide encompassing a sequence within the central region of human CD3d.
Epitope
Internal
Specificity
Recognizes endogenous levels of CD3d protein.
Applications
  • ICC (1:100 - 1:500)
  • Immunofluorescence
  • Western blot (1:500 - 1:1000)
Presentation
PBS, pH 7.3, 0.01% Sodium Azide, 30% Glycerol
Storage
Store at -20°C. Aliquot to avoid freeze/thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About CD3D
P04234 NM_000732 NP_000723.1

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 11/26/2024